Trimetazidine for stable angina (Q24245946)

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Coronary artery disease observed in general hospitals: ETTIC study. Comparison between trimetazidine and mononitrate isosorbide for patients receiving betablockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Treatment of stable angina with low dose diltiazem in combination with the metabolic agent trimetazidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Choosing the most appropriate treatment for stable angina. Safety considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Can improved quality of care reduce the costs of managing angina pectoris?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Trimetazidine for stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Metabolic management of ischemic heart disease: clinical data with trimetazidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Language bias in randomised controlled trials published in English and German.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Implications of the atorvastatin versus revascularization treatment (AVERT) study for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Mechanisms of nitrate tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Is cholesterol lowering an alternative to revascularization in some patients with coronary artery disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Treatment of stable angina. Use drugs before percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Ranolazine: a novel metabolic modulator for the treatment of angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Twenty-two-year follow-up in the VA Cooperative Study of Coronary Artery Bypass Surgery for Stable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Characteristics of a contemporary population with angina pectoris. TIDES Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Chronic coronary artery disease: drugs, angioplasty, or surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Treatment of stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

21 January 2018

Meta-Analysis in Stata™

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Controversies in meta-analysis: the case of the trials of serum cholesterol reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

National patterns and predictors of beta-blocker use in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Chronic effects of trimetazidine on ergometric parameters in effort angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Combination of trimetazidine with nifedipine in effort angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Acute effects of trimetazidine evaluated by exercise testing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

The Effect of Trimetazidine in the Treatment of Microvascular Angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

The effect of trimetazidine on reperfusion arrhythmias in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Trends in acute myocardial infarction and coronary heart disease death in the United States

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: contribution of Holter electrocardiographic ambulatory monitoring

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Factors relevant to the validity of experiments in social settings.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardi

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

How European cardiologists perceive the role of calcium antagonists in the treatment of stable angina.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Combination treatment with trimetazidine and diltiazem in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Effect of nicotinic acid on myocardial metabolism in man at rest and during exercise

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on M

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Profile of an ideal antianginal agent.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003614.PUB2

7 January 2021

Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003614.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003614.PUB2

Myocardial protection during coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled study with trimetazidine.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003614.PUB2

Identifiers

DOI

10.1002/14651858.CD003614.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

3321091

3321091

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference